Article ID Journal Published Year Pages File Type
9385289 Journal of Cystic Fibrosis 2005 6 Pages PDF
Abstract
Long-term, low-dose AZ treatment in adult CF patients with chronic P. aeruginosa infection is safe and reduces the decline in lung function, increases weight, and reduces the percentage of mucoid strains of P. aeruginosa in sputum samples.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Preview
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study
Authors
, , , ,